Skymax Lifescience Private Limited, a active private limited company, was established on 15 January 2010 in Choryasi, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24233GJ2010PTC059242. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.60 M and a paid-up capital of ₹2.60 M.
It upholds a compliant status. Employing 2 professional, Its leadership includes Kirtikumar Dhirubhai Meghani (Director), Maulik Meghjibhai Patel (Director), Pankaj Maganbhai Padmani (Director). Past directors included Khushboo Maheshbhai Shah, Mahesh Chandulal Shah. It holds ₹3.35 Cr open charges and ₹3.77 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Landmark Empire Build - A,, Sh-509/510 Landmark Corp -A, Choryasi, Gujarat, 395010.
U24233GJ2010PTC059242
059242
15 January 2010
₹2.60 M
₹2.60 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Skymax Lifescience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kirtikumar Dhirubhai Meghani | Director | 14 Apr 2010 | Current |
| Maulik Meghjibhai Patel | Director | 15 Feb 2012 | Current |
| Pankaj Maganbhai Padmani | Director | 03 Dec 2014 | Current |
| Pareshkumar Arvindkumar Shah | Director | 07 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Feb 2012 | Past |
| Pramod Abcsdd | Director | 15 Feb 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Skymax Lifescience Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.14% decrease. The company also saw a substantial fall in profitability, with a 41.32% decrease in profit. The company's net worth moved up by a moderate rise of 9.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Skymax Lifescience had a promoter holding of 64.67% and a public holding of 35.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹33,504,248.00
₹37,704,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 May 2025 | Others | ₹3.25 Cr | Open |
| 15 Oct 2024 | Hdfc Bank Limited | ₹0.50 M | Open |
| 20 Oct 2023 | Bank Of India | ₹0.50 M | Open |
| 21 Aug 2021 | Hdfc Bank Limited | ₹4.55 M | Satisfied |
| 31 May 2021 | Hdfc Bank Limited | ₹0.40 M | Satisfied |
Explore comprehensive loan charge details -
Skymax Lifescience has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Skymax Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skymax Lifescience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 21 Aug 2021 via Charge ID 100474800 with Hdfc Bank Limited was fully satisfied on 04 Jul 2025. was documented.
The activity A charge registered on 04 Jul 2017 via Charge ID 100114222 with Hdfc Bank Limited was fully satisfied on 03 Jul 2025. was completed.
The activity A charge with Others amounted to Rs. 32.50 M with Charge ID 101092150 was registered on 13 May 2025. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 0.50 M with Charge ID 100987138 was registered on 15 Oct 2024. was recorded as a recent event.
Progress on Skymax Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge registered on 31 May 2021 via Charge ID 100453777 with Hdfc Bank Limited was fully satisfied on 05 Jun 2024. was recorded as a recent event.
The CIN of Skymax Lifescience Private Limited is U24233GJ2010PTC059242.
Skymax Lifescience Private Limited is headquartered at Landmark Empire Build - A,, Sh-509/510 Landmark Corp -A, Choryasi, Gujarat, 395010.
Skymax Lifescience Private Limited was incorporated on 15 January 2010.
The current directors of Skymax Lifescience Private Limited are
The primary industry of Skymax Lifescience Private Limited is Trade.
Skymax Lifescience Private Limited is unlisted.
The authorized capital of Skymax Lifescience Private Limited is ₹2.60 M, and the paid-up capital is ₹2.60 M.
The compliance status of Skymax Lifescience Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX